Suggestions
Rachel Frizberg
Area Head APAC, Roche Pharma International
Professional Background
Rachel Frizberg is a dynamic and experienced professional in the pharmaceutical industry, holding the esteemed position of Area Head for Asia Pacific (APAC) at Roche Pharma. Over the past 20 years, Rachel has made a significant impact in the industry through her role as a leader and collaborator, fostering innovation to accelerate the delivery of treatments to patients across the region. Her commitment to empowering local executives is driven by her dedication to overcoming the evolving healthcare needs in the APAC market.
With a career that began in business development, Rachel eventually moved to Asia in 2012, where she has been instrumental in recognizing and harnessing unique opportunities within the diverse healthcare landscapes of the region. She embodies Roche’s mission of enhancing healthcare sustainability and making medications more accessible to patients, emphasizing the importance of collaboration in addressing the pressing healthcare challenges faced by countries in the APAC area.
Rachel has a proven track record of leading multidisciplinary teams to realize the vast potential within various markets. Her leadership philosophy centers around the idea of enabling her colleagues and stakeholders to develop innovative and effective solutions that ultimately benefit patients. By serving as a coach and mentor, she helps cultivate a collaborative environment that encourages creativity and forward-thinking approaches.
Education and Achievements
Rachel is a proud alumna of Oxford Brookes University, where she studied Business & Finance. Her educational background has laid a solid foundation for her successful career in the pharmaceutical industry, allowing her to approach business challenges with both analytical and strategic insight.
Throughout her illustrious career at Roche, Rachel has held numerous key positions that underline her leadership capabilities and dedication to the industry. Her former roles include:
- Commercial Director, Region Europe
- President, The Hong Kong Association of Pharmaceutical Industry
- General Manager
- Regional Disease Area Manager, Western Europe
- International Business Leader, Inflammation
- International Business Leader, Aleglitazar (Metabolism)
- International Product Manager, Bonviva (Metabolism)
- Senior Global Marketing Manager, Ketek (Anti-infectives)
- Marketing Manager, Aventis
- Product Manager, Ferring Pharmaceuticals
- Brand Manager, Respiratory Marketing at Glaxo Wellcome UK Limited
- Customer & Field Interface Executive, Respiratory Marketing
- Communication Coordinator, Sales Directorate (Head Office)
- Respiratory Market Development Executive
- Management Trainee & Business Development Executive at Bayer
These roles have equipped her with substantial industry insight, strategic vision, and the ability to lead effectively in various corporate environments.
Achievements
Rachel's commitment to improving patient care is evident through her advocacy for collaborative efforts within the healthcare ecosystem of the APAC region. As the Area Head at Roche Pharma, she has been pivotal in shaping strategic initiatives that align with the growing healthcare demands caused by an aging population and increasing disease burdens. Under her guidance, numerous multidisciplinary teams have devised innovative treatments and solutions that address both immediate and long-term healthcare challenges in the region.
Additionally, her leadership as President of the Hong Kong Association of Pharmaceutical Industry highlights her influence and dedication to advancing pharmaceutical policies and practices that benefit not only companies but also the patients they serve. Rachel’s extensive experience managing product launches and leading marketing campaigns across various therapeutic areas has greatly contributed to the success of Roche’s product portfolios in APAC.
Throughout her career, Rachel has fostered a culture of creativity and patient-centricity, aiming to bridge healthcare delivery gaps by developing sustainable and accessible healthcare solutions. Her collaborative approach has not only empowered her teams but has also created strong partnerships across the industry, enabling a unified response to the evolving challenges of healthcare delivery in the APAC region.